🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
Breast cancer is the most common malignant tumor in women. Recurrent or met...
Status
Recruiting
Location
Shusen Wang
Start Date
2018-07-25
Trial ID
NCT03561740
Treatments Being Tested
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
ACTIVE is a prospective, single-arm, phase I/IIa study examining an active ...
Status
Recruiting
Location
University of Pittsburgh Medical Center
Start Date
2025-11-01
Trial ID
NCT07262138
Treatments Being Tested
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
In the REaCT-Vascular Access Her2 negative study, the investigator will use...
Status
Completed
Location
The Ottawa Hospital Cancer Centre
Start Date
2016-04
Trial ID
NCT02688998
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
The investigators designed a phase III clinical trial involving hormone rec...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-07
Trial ID
NCT07213206
Treatments Being Tested
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
In this study, 60 patients with HER2 overexpression UTUC with high-risk rec...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2024-02-20
Trial ID
NCT06210490
Treatments Being Tested